MEAGHAN BROWN: Open Payments
NPI 1699250787 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,462 in 58 payments from 25 companies in 2025. Trend: 2023 $1,396 · 2024 $1,088 · 2025 $1,462
Food & beverage: $1,363Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $198 |
| Merck Sharp & Dohme LLC | 7 | $191 |
| Daiichi Sankyo Inc. | 5 | $121 |
| GlaxoSmithKline, LLC. | 4 | $105 |
| Incyte Corporation | 1 | $99 |
| PharmaEssentia USA Corporation | 4 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| PFIZER INC. | 3 | $72 |
| Janssen Biotech, Inc. | 3 | $63 |
| Ipsen Biopharmaceuticals, Inc | 2 | $58 |
Products named: KEYTRUDA, Enhertu, BESREMI, OJJAARA, TAGRISSO, VENCLEXTA, Onivyde, Nubeqa.
Industry payments across TX — which companies pay providers there.
